The Best Multidisciplinary care in Bellevue, Nebraska

The Nebraska Medicine Cancer Center at Bellevue Medical Center is a leading healthcare institution located at 2510 Bellevue Medical Center Drive in Bellevue, Nebraska, United States. As a specialized cancer center, we provide cutting-edge treatments and compassionate care to patients battling cancer. Our team of dedicated healthcare professionals is committed to delivering personalized care and support to each individual, ensuring the best possible outcomes. With state-of-the-art facilities and a multidisciplinary approach to treatment, we strive to improve the lives of our patients and their families. Visit us today to learn more about our comprehensive cancer care services.

Dr. Jairam Krishnamurthy is an Associate Professor of Medicine specializing in Hematology and Oncology at the University of Nebraska Medical Center. Located at 505 South 45th Street in Omaha, Nebraska, Dr. Krishnamurthy serves as the Co-Director of the breast cancer program, providing care for patients with various subtypes of breast cancer. Certified by the American Board of Internal Medicine in Internal Medicine, Hematology, and Medical Oncology, Dr. Krishnamurthy has extensive experience and expertise in the field. He has authored numerous articles, book chapters, and abstracts, and serves as an expert reviewer for scientific journals and conferences.

Dr. Jairam Krishnamurthy is an Associate Professor of Medicine specializing in Hematology and Oncology at the University of Nebraska Medical Center. He is the Co-Director of the breast cancer program and works as part of a multi-disciplinary team to provide care for patients with different types of breast cancer. Dr. Krishnamurthy is board certified in Internal Medicine, Hematology, and Medical Oncology, and has extensive experience in research and publication in the field. He is actively involved in the development of guidelines for breast cancer management as a member of the NCCN expert panel. Dr. Krishnamurthy also serves as the Associate Director for the hematology and medical oncology fellowship program. His practice locations include the Cancer Center at Bellevue Medical Center, Fred & Pamela Buffett Cancer Center, and Nebraska Medicine Village Pointe.

Kelsey Klute, MD, is an Associate Professor specializing in Oncology & Hematology with a focus on Gastrointestinal and Pancreatic Cancer. Located at 505 South 45th Street in Omaha, Nebraska, Dr. Klute and her team provide expert, multidisciplinary care for patients with cancers of the gastrointestinal tract. As the Medical Director for the Cancer Risk and Prevention Clinic at Nebraska Medicine, Dr. Klute is dedicated to improving outcomes through early detection, prevention, and innovative therapeutic approaches. She is actively involved in research, leading studies to develop biomarkers for early pancreatic cancer detection and collaborating with international researchers through the PRECEDE Consortium. Dr. Klute's commitment to patient care, research, and education has earned her recognition as a top teacher and leader in the field of gastrointestinal cancer treatment. Visit Dr. Klute at the Fred & Pamela Buffett Cancer Center, Cancer Center at Bellevue Medical Center, or Cancer Center at Village Pointe Health Center for personalized, comprehensive care.

Kelsey Klute is an institution located at 2510 Bellevue Medical Center Drive in Bellevue, Nebraska, United States. Dr. Klute is an Associate Professor specializing in Oncology & Hematology, with a focus on Gastrointestinal Cancer and Pancreatic Cancer. Dr. Klute and her team provide multidisciplinary care tailored to each patient's unique cancer, while also addressing the impact of cancer and its treatment on quality of life. She is the Medical Director for the Cancer Risk and Prevention Clinic at Nebraska Medicine and is actively involved in teaching medical students, residents, and fellows. Clinic locations include the Fred & Pamela Buffett Cancer Center, Cancer Center at Bellevue Medical Center, and Cancer Center at Village Pointe Health Center. Dr. Klute's research is dedicated to improving outcomes in pancreatic cancer through early detection, prevention, and the development of novel therapeutic approaches. She leads a large, prospective study focused on developing biomarkers for early pancreatic cancer detection and collaborates internationally through the PRECEDE Consortium.